type 2 diabetes therapy (Metcon Medicin)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nametype 2 diabetes therapy (Metcon Medicin)
Drug Alias NameIGT/type 2 (Metcon Medicin)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMetcon Medicin
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMetcon Medicin
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A